A chemistry analysis conducted by Jellagen Pty Ltd into the functionalisation of collagen and its fabrication into novel wound healing devices targeting diabetic foot ulcers.

点击翻译按钮获取中文摘要

Jellagen Pty Ltd (JPL) aims to conduct a Proof of Concept research project into thefunctionalisation of collagen and its fabrication into novel wound healing devices. The projectaims to evaluate the potential of incorporating functionalised collagen into wound healingdevices for a range of applications including the treatment of diabetic foot ulcers (DFU). Thisnovel wound healing device is designed to replace existing technologies for DFU and otherwound healing applications, as a more effective, easier to use and more accessible treatmentoption. The device will be constructed from our novel jellyfish collagen. Jellyfish collagen isa highly biocompatible biomaterial that has shown improved efficacy and performance overexisting mammalian sourced collagen, and as a result it is an ideal material from which toconstruct wound healing devices. This means that the finished device has the potential torevolutionise the treatment of DFU, reducing economic pressure on health services andimproving the treatment of and quality of life for sufferers of DFU.